Login / Signup

Correction: In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis.

Juan Martin ArriagaKacey Ronaldson-BouchardFlorencia PicechFrancisca Nunes de AlmeidaStephanie AfariHoussein ChhouriGordana Vunjak-NovakovicCory Abate-Shen
Published in: Oncogene (2024)
Keyphrases
  • genome wide
  • prostate cancer
  • dna methylation
  • radical prostatectomy
  • bone mineral density
  • copy number
  • soft tissue
  • bone loss
  • bone regeneration
  • postmenopausal women
  • gene expression
  • crispr cas
  • genome editing